Pelvic Pain

01/01/2019 - "Clinician and patient factors impact on the management of chronic pelvic pain (CPP) with medical, surgical or combined approaches possible, although none have proven superior. "
01/01/2022 - "Management of chronic pelvic pain (CPP) remains a huge challenge for care providers and a major burden for healthcare systems. "
03/01/2020 - "Forty-four percent and 38% of patients with chronic pelvic pain (CPP) presented an improvement in postoperative PCS and Mental Component Summary scores (ES>0.8) versus 23% and 24% of patients without CPP, respectively (p <.001). "
12/01/2019 - "Objective: To summarize the available scientific evidence on physiotherapy interventions in the management of chronic pelvic pain (CPP). "
08/01/2017 - "To provide an update on nonsurgical and nonpharmacologic strategies for the management of chronic pelvic pain (CPP). "

03/01/1997 - "The author outlines the cost effectiveness of a trial course of GnRH agonists in women presenting with chronic pelvic pain."
11/01/2009 - "Long-term use of GnRH agonist plus immediate add-back HRT is a safe and acceptable approach to intractable cyclical pelvic pain. "
02/01/1996 - "Suppression of ovarian function by GnRH analogues may allow differentiation of pelvic pain caused by the residual ovary syndrome from other causes. "
02/01/1996 - "GnRH analogue in assessing chronic pelvic pain in women with residual ovaries."
02/01/1995 - "In this report we describe the successful use of the gonadotropin releasing hormone agonist (GnRH-a) stimulation test to identify the presence of functioning ovarian tissue in three women with ovarian remnant syndrome who presented for evaluation of persistent chronic pelvic pain. "

01/01/2023 - "After 6 months follow-up assessments the pelvic pain score was significantly lower in Dienogest group than MPA group (P < 0.001). "
01/01/2012 - "A significant decrease in pelvic pain was shown during continued dienogest treatment (P < 0.001). "
09/01/2015 - "The extended therapy with dienogest 2 mg/day also showed an improvement in pelvic pain after 24-52 weeks (-22.5 ± 32.1 and -28.4 ± 29.9 mm, respectively) with tolerable side effects. "
11/12/2010 - "In randomized clinical trials, oral dienogest was significantly more effective than placebo in reducing pelvic pain in patients with confirmed endometriosis. "
12/01/2021 - "Both treatments improved the mean VAS score for endometriosis-associated pelvic pain significantly: mean difference 6.0 [95% confidence interval (CI) 4.9-7.1; p < 0.0001] in the dienogest group and 4.54 (95% CI 3.1-5.9; p < 0.0001) in the COC group; the difference between them was not significant (p = 0.111). "

01/01/2020 - "Given the increasing reports of abuse and evidence of potential harms associated with gabapentin use, it is important that clinicians consider alternative treatment options to off-label gabapentin for the management of chronic pelvic pain and no obvious pelvic pathology. "
01/01/2017 - "Is gabapentin effective for women with unexplained chronic pelvic pain?"
01/01/2022 - "Is gabapentin effective and safe in the treatment of chronic pelvic pain in women: a systematic review and meta-analysis."
02/01/2022 - "This study aimed to assess the efficacy of gabapentin when administered to women with chronic pelvic pain without another diagnosis. "
01/01/2018 - "GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol."

01/01/2023 - "Efficacy of botulinum toxin A injection in pelvic floor muscles in chronic pelvic pain patients: a study protocol for a multicentre randomised controlled trial."
11/01/2022 - "This study was conducted to review and meta-analyse the current literature on the reduction of chronic pelvic pain after botulinum toxin A (BTA) injection. "
01/01/2022 - "Botulinum Toxin-A Injection in Chronic Pelvic Pain Syndrome Treatment: A Systematic Review and Pooled Meta-Analysis."
01/01/2022 - "The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel."
01/01/2021 - "Botulinum toxin A injection in the treatment of chronic pelvic pain with hypertonic pelvic floor in women: Treatment techniques and results."

12/01/2021 - "She presented to the emergency department two days after completing the course of antibiotics where she complained of worsening pelvic pain, reduced foetal movements and passing black urine. "
08/01/2013 - "The patient defervesced after 6 days of intravenous antibiotics, but the pelvic pain did not improve. "
01/01/2013 - "The aim of our work was to evaluate the response to an antifungal regimen in the setting of patients presenting with symptoms of chronic pelvic pain syndrome that have been refractory to treatment with antibiotics and alpha-blockers. "
02/01/2009 - "Despite treatment with broad-spectrum parenteral antibiotics, the patient remained febrile with persistent pelvic pain. "
05/01/2008 - "Despite evidence that antibiotics are not effective in the majority of men with chronic pelvic pain syndrome, they were prescribed in 69% of men with this diagnosis. "

03/05/2014 - "Evidence of moderate quality supports progestogen as an option for chronic pelvic pain, with efficacy reported during treatment. "
02/01/1999 - "Progestins are efficient on pelvic pain, contra-indications, clinical and metabolic tolerance are linked to the hormonal activity of the molecules. "
09/01/1997 - "The available data suggest that the efficacy of progestins for temporary relief of endometriosis-associated pelvic pain is good and comparable to that of other, less safe treatments."
04/01/2018 - "Randomized, controlled, non-blinded studies support the use of oral progestin-only treatment for pelvic pain associated with endometriosis. "
01/01/2018 - "Most women with endometriosis-associated pelvic pain who chose a stepped-care approach were satisfied with OC and a low-cost progestin for the treatment of their symptoms. "

07/01/2005 - "The current approach to treatment of chronic pelvic pain in Italy involves first-line treatment with oral contraceptives or nonsteroidal antiinflammatory drugs. "
03/01/1995 - "The only exception was pelvic pain which was reported to be improved by oral contraceptive use. "
08/01/1996 - "Finally, a trial of oral contraceptives may be used as initial screening in women with chronic pelvic pain to reduce the number of unnecessary diagnostic and surgical interventions."
04/01/2000 - "Two different groups of women, 23 healthy young adults and 13 women with chronic posterior pelvic pain, were studied before and during use of oral contraceptives (OC). "
12/01/1997 - "Chronic pelvic pain: oral contraceptives and non-steroidal anti-inflammatory compounds."

10/01/2010 - "The following is a report of a patient who experienced symphysiolysis-like pelvic pain following the use of a levonorgestrel-releasing intrauterine system."
01/01/2010 - "Local treatment with the levonorgestrel-releasing intrauterine system is an option for long-term suppression of pelvic pain."
11/01/2008 - "Is there a role for use of levonorgestrel intrauterine system in women with chronic pelvic pain?"
01/01/2023 - "However, the levonorgestrel intrauterine system was superior in reducing spotting from 9 months onward, and it reduced the absolute number of spotting days from 6 months onward and pelvic pain from 3 months onward."
01/01/2021 - "Levonorgestrel (LNG) IUDs also have beneficial effects on menstrual bleeding and abdominal and pelvic pain. "

01/01/2020 - "The add-on of cernitin was more effective than tadalafil for pelvic pain and discomfort."
01/01/2020 - "Both cernitin and tadalafil significantly ameliorated chronic pelvic pain in patients with refractory CP/CPPS. "
01/01/2019 - "In HCP, tadalafil suppressed the pelvic-pain-related behavior. "
01/01/2019 - "Tadalafil significantly attenuated the chronic pelvic pain in both models."
01/01/2019 - "Repeated treatment with tadalafil attenuated the chronic pelvic pain in both models. "

01/01/2018 - "The phenotyping system UPOINT has proven effective in classifying patients with Urologic Pelvic Pain Syndromes in a clinically meaningful way and to guide therapy. "
01/01/2009 - "The mean E2 level during draw-back therapy was 36.3+/-14.3 pg/ml. The intensity of chronic pelvic pain was significantly lower during draw-back therapy than before draw-back therapy, and was nearly eliminated in many patients (4.8+/-1.2 vs. 0.6+/-0.7, respectively [p=0.000]). "
03/01/2003 - "As far as pelvic pain is concerned, more data are needed to verify the reduced symptoms recurrence rate found in four trials in women who were allocated to postoperative medical therapy, particularly in view of the different results obtained in some of the considered studies. "
01/01/2021 - "Compared to chemo or targeted therapy alone, LEER improved survival in patients with PSRCC and PTFI < 9.2 months, and it was effective at controlling the pelvic pain associated with PSRCC. "
03/01/2020 - "Low intensity-shokwave therapy (Li-ESWT) is effective in chronic pelvic pain syndrome treatment."

07/01/2004 - "Both procedures substantially improved symptoms for most patients, with an advantage for hysterectomy at 12 months for pelvic pain. "
04/01/1990 - "Patients were followed after hysterectomy for an average of 21.6 months (range 15-64), with 77 of 99 (77.8%) showing significant improvement and 22 (22.2%) having persistent pelvic pain. "
01/01/2022 - "Individual patient factors including younger age, lower baseline sexual function, and short duration of pelvic pain are associated with a higher likelihood of improvement in sexual function after hysterectomy. "
03/01/2006 - "In this study,however, a greater proportion of patients who underwent hysterectomy had improved pelvic pain scores. "
11/01/2021 - "Multivariate logistic regression was used to identify the independent predictors of persistent pelvic pain 6 months following hysterectomy, defined as <50% improvement in pelvic pain severity. "

01/01/2015 - "In published work review, extracorporeal shock wave therapy (ESWT) has been showed to be effective in treating chronic perineal/pelvic pain in men, but there was no published report on its use in women. "
07/01/2022 - "Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome IIIb: A Prospective-Randomized, Double-Blind, Placebo-Controlled Study."
01/01/2019 - "Efficacy of Radial Extracorporeal Shock Wave Therapy for Chronic Pelvic Pain Syndrome: A Nonrandomized Controlled Trial."
03/01/2021 - "A systematic review of the evidence was conducted to evaluate the efficacy of low-intensity extracorporeal shock wave therapy (LI-ESWT) for patients with chronic pelvic pain syndrome (CPPS). "
12/01/2020 - "Applying low-intensity extracorporeal shockwave therapy (LI-ESWT) has been reported to improve symptoms of refractory chronic pelvic pain syndrome (CPPS) in short-term follow-up. "

11/01/2013 - "Transvaginal physical therapy is an effective treatment for chronic pelvic pain resulting from myofascial pelvic pain."
03/01/2008 - "A review of the relevant literature was performed, clarifying current definitions of pelvic pain, elucidating the role of musculoskeletal factors, and determining the efficacy of physical therapy interventions. "
10/01/2020 - "The objective of this study was to compare structured group-based multimodal physical therapy in a hospital setting (intervention group) with primary-care physical therapy (comparator group) for women with chronic pelvic pain. "
01/01/2013 - "Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes."
08/01/2009 - "Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes."

08/15/2006 - "Presacral neurectomy is particularly beneficial in women with midline pelvic pain. "
08/01/1994 - "Efficacy of Presacral Neurectomy for the Relief of Midline Pelvic Pain"
03/01/2012 - "Robotic presacral neurectomy is safe and feasible, resulting in improvement of pelvic pain in selected patients."
03/01/2012 - "A retrospective analysis was performed of 33 patients with midline chronic pelvic pain, who underwent robotic presacral neurectomy. "
07/01/2010 - "All patients had central pelvic pain, the primary indication for presacral neurectomy. "